FYI...
"When the safety of Pfizer's stop-smoking drug Chantix is debated, usually the focus is on the drug's potential link to psychiatric side effects. But now U.S. regulators have warned that the drug can also boost the risk of cardiovascular problems, including heart attacks."
"When the safety of Pfizer's stop-smoking drug Chantix is debated, usually the focus is on the drug's potential link to psychiatric side effects. But now U.S. regulators have warned that the drug can also boost the risk of cardiovascular problems, including heart attacks."